| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab177906-100μg |
100μg |
现货  |
| |
| Ab177906-1mg |
1mg |
现货 |
| |
| Ab177906-5mg |
5mg |
现货 |
| |
| Ab177906-10mg |
10mg |
期货 |
|
| 产品名称 | Lupartumab (anti-LYPD3) |
|---|---|
| 别名 | 2310061G07Rik antibody | C4.4A antibody | GPI-anchored metastasis-associated protein C4.4A homolog antibody | GPI-anchored metastasis-associated protein homolog antibody | Ly6/PLAUR domain-containing protein 3 antibody | Lypd3 antibody | LYPD3_HUMAN antib |
| 英文别名 | 2310061G07Rik antibody | C4.4A antibody | GPI-anchored metastasis-associated protein C4.4A homolog antibody | GPI-anchored metastasis-associated protein homolog antibody | Ly6/PLAUR domain-containing protein 3 antibody | Lypd3 antibody | LYPD3_HUMAN antib |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | LYPD3 |
| 种属反应性 | 人(Human),小鼠(Mouse),食蟹猴(Cynomolgus monkey) |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | lambda |
| SDS-PAGE | 26.7kDa (Light Chain) & 50.0 kDa (Heavy Chain), under reducing conditions; 188.6 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1640971-88-5 |
| 分子类型 | 抗体 |
Lupartumab (anti-LYPD3) (Ab177906) - Flow Cytometry
Flow Cytometry analysis of MCF-7 cells labelling LYPD3 (red) with Lupartumab (anti-LYPD3) (Ab177906). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Lupartumab (anti-LYPD3) (Ab177906) - SEC
The purity of Lupartumab (anti-LYPD3) (Ab177906) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
 ZJ24F1013248 |
分析证书 | 24-11-01 | Ab177906 |
| ZJ24F1013247 |
分析证书 | 24-11-01 | Ab177906 |
| ZJ24F1013246 |
分析证书 | 24-11-01 | Ab177906 |
| ZJ24F0404116 |
分析证书 | 24-04-03 | Ab177906 |
| ZJ24F0404117 |
分析证书 | 24-04-03 | Ab177906 |
| ZJ24F0404118 |
分析证书 | 24-04-03 | Ab177906 |
| 1. Würfel, J J and 10 more authors.. (2001) Cloning of the human homologue of the metastasis-associated rat C4.4A.. Gene, (10): [PMID:11179665] |
| 2. Smith, B A BA and 5 more authors.. (2001) Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium.. Cancer research, (15): [PMID:11245483] |
| 3. Fletcher, G C GC and 10 more authors.. (2003) hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan.. British journal of cancer, (24): [PMID:12592373] |
| 4. Hansen, Line V LV and 6 more authors.. (2004) Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.. The Biochemical journal, (15): [PMID:15012588] |
首页
400-620-6333
